ImmunityBio (IBRX) Q4 2024 Earnings

12NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.36
-0.29
-0.21
-0.14

Details

Expected EPS
-0.178033
Actual EPS
-0.14
Surprise EPS
0.04
Surprise Percent
+21.36%

Description

ImmunityBio (IBRX) has reported earnings of -0.14 per share for Q4 2024.

0 Comments

Share your thoughts